Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Neurone

Ataxias

Causes, biological mechanisms, symptoms, diagnosis and treatment

Last update: 09/11/2024 Reading time: 1min

Ataxias (etymologically disorders), also known as cerebellar syndromes, are a group of neurodegenerative diseases of the cerebellum and/or brain stem, which result in problems with the coordination of voluntary movements without muscular weakness, balance and ocular damage. They affect around 1 in 10,000 people in France and most other European countries.

These diseases are due to dysfunctions in neuronal transmission in the cerebellum and in the nerve bundles connected to it. The cerebellum is the part of the brain responsible for coordinating voluntary movements. The first sign of ataxia is often a loss of balance, which progresses steadily towards incoordination affecting walking, posture, speech or eye movements, for example.

A distinction is made between ataxia of genetic origin, which affects both sides of the body and progresses slowly, and acquired ataxia, which occurs suddenly after a sudden brain injury. Acquired ataxia may be caused by a tumour, ruptured aneurysm or cerebral infection, but also by alcohol abuse or chemical intoxication. There are also congenital ataxias due to developmental malformations of the brain.

Causes and biological mechanisms

The causes and biological mechanisms of ataxia

Ataxias do not result from muscular weakness, but are caused by dysfunction of the central nervous system. Cerebellar ataxias occur when the cerebellum is affected; sensory ataxias are caused by damage to the spinal cord, and vestibular ataxias can also be distinguished. There are ataxias of genetic origin due to mutations in various genes (over 50 known to date) and acquired ataxias of sudden onset, caused by damage to the brain or spinal cord. To find out more about the causes of ataxia, visit our dedicated page.

Symptoms and diagnosis

Symptoms and diagnosis of ataxia

Cerebellar ataxias are characterised by a loss of coordination, with apraxia preventing patients from controlling the position of their limbs or their posture. Depending on the type of ataxia, dysmetria (loss of control over the amplitude of voluntary movements), dysarthria (loss of control over speech and its amplitude), nystagmus (loss of control over eye movements) and tremors may appear.

The diagnosis of ataxia is based on a clinical examination, brain imaging, electrophysiology tests and genetic analysis in family cases.

Treatments

Treatments for ataxia

There is currently no approved treatment for cerebellar ataxia of genetic origin, for which physiotherapy, occupational therapy or speech therapy can relieve the symptoms.

Acquired ataxias can be treated according to their origin, whether toxic, traumatic or inflammatory. In the case of ataxia resulting from a brain tumour, for example, treatment with chemotherapy or surgery to eliminate the tumour will reduce or even eliminate the symptoms of ataxia.

Our news on the subject

cervelet
Spinocerebellar ataxias: a widely underestimated diversity
Spinocerebellar ataxias are a very heterogeneous group of inherited diseases associated with degeneration of the cerebellum – a region at the back of the skull that plays an essential role in motor control. Patients have gait and balance disorders...
06.21.2023 Research, science & health
cerveau
Spinocerebellar ataxia type 2: a therapeutic trial opens new avenues
A clinical trial conducted by Prof. Alexandra Durr's team (Sorbonne University.AP-HP) at the Paris Brain Institute and the Pitié-Salpêtrière Hospital AP-HP shows that despite the hopes raised in recent years, riluzole does not improve the clinical or...
01.19.2022 Research, science & health
ataxie cervelet
Channels strike again: a common battle for axatias and epilepsy?
Giovanni Stevanin, researcher at the Brain and Spine Institute (Institut du Cerveau - ICM), and his collaborators identified a recurring mutation in a new gene responsible for cerebellar axatia that en-codes a calcium channel expressed in certain...
10.22.2015 Research, science & health
FRAMES : un essai thérapeutique sur l'ataxie de Friedreich
Improvement: type 7 spinocerebellar ataxia
The aim of Dr A. Sittler, from the Alexis Brice and Giovanni Stevanin team, is to develop a new therapeutic strategy for the spinocerebellar ataxia SCA7.
06.27.2013 Research, science & health
See all our news